Images
Participants
Contact
“The Scientist” reports on a study headed by ICREA researcher Salvador Aznar Benitah, from the Stem Cells and Cancer Lab at IRB Barcelona, and whose first author is Gloria Pascual. In the study, published in Nature, the researchers reveal that, in mice, the human oral cancer cells that are most likely to migrate from primary tumors are marked by the surface protein CD36—a scavenger receptor that binds fatty acids.
The report includes a second study, by the Wellcome Trust Sanger Institute in Cambridge, which highlights this role for lipid signaling in the tumor microenvironment.
Link to The Scientist
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
